Aurobindo Pharma consolidated revenue from operation grew 15.5% on a YoY basis to `4250.27 Crs. in Q1. Growth has been aided by API segment, US, and Europe formulation business segments. However, the ARV business contracted 36% on YoY basis due to weak...